IMMU-03 CD200 Expression by Glioma Cells Suppresses Anti-tumor Immunity and Limits Therapeutic Response
Pediatric high-grade gliomas are among the most lethal malignancies, characterized by aggressive growth, profound immunosuppression, and limited therapeutic options. Although immune checkpoint inhibitors have produced durable responses in several systemic cancers, their efficacy in neuro-oncology remains consistently...